Coldact Sinus

It is not recommended to consume alcohol during treatment with Coldact Sinus, as it contains paracetamol and the combination with alcohol significantly increases the risk of liver damage. Chronic alcohol consumption can increase the liver toxicity of paracetamol, even at therapeutic doses.

Taking Coldact Sinus with other cold medicines is not recommended without medical advice, as it may lead to an overdose of paracetamol or other common active substances. Combining several products may increase the risk of side effects such as drowsiness, increased blood pressure or liver damage.

Long-term use of Coldact Sinus is not recommended, as it may increase the risk of side effects such as high blood pressure or sleep disorders. If symptoms persist, consult a doctor to identify the cause and adjust the treatment.

Curiosin by Gedeon Richter is a topical preparation for the treatment of skin lesions, containing zinc hyaluronate as its main active ingredient – a compound with remarkable properties in supporting tissue regeneration. Thanks to its composition, Curiosin creates an optimal microclimate for wound healing, promoting the epithelialisation process.

Forms of release

The product is available as a transparent, odourless gel that does not stain the skin or clothing. The gel comes in a concentration of 0.1% in a 15 g tube.

The composition includes zinc hyaluronate, carbomer (gelling agent), potassium sorbate (preservative) and purified water.

Indications for use

Curiosin is indicated for the care of affected or problematic skin, as well as for the treatment of acute or chronic wounds. There are two types of use:

• Without a prescription, in the following cases:
  • Skin irritation caused by radiation;
  • Dry or flaky skin;
  • Superficial wounds (abrasions, minor cuts, scratches);
  • Mild burns (first and second degree);
  • Mild to moderate acne vulgaris.
• Under medical supervision, for:
  • Chronic wounds such as venous leg ulcers, eschar, diabetic ulcers;
  • Closed surgical wounds;
  • Postoperative care of incisions.

Dosage regimen

Curiosin is administered exclusively by topical application. Before application, the affected area should be thoroughly cleaned with water or saline solution. Apply a thin layer (approximately 1 mm) to the entire surface of the wound.

• For dry, irritated or problematic skin, the gel can be applied several times a day, as needed.
• In the case of superficial wounds, covering with a sterile dressing is optional.
• For minor burns, it is recommended to initially cool the affected area under running water, followed by application of the gel.
• For chronic or surgical wounds, use should only be under medical supervision as part of a complex therapy (e.g. infection control, compression, blood sugar control).

Contraindications

Curiosin is contraindicated in cases of known hypersensitivity to any of the product's components, including zinc hyaluronate or potassium sorbate.

Curiosin should not be applied to mucous membranes, in the eyes or in internal cavities.

Special instructions for use

The tip of the tube should not touch the wound or other surfaces to avoid contamination. It is recommended that the product be used by a single patient to prevent the risk of infection.

Once opened, the tube should be used within 4 weeks and the cap should be tightly closed after each use.

The gel can be used on children and adults, but in the case of chronic wounds, medical advice should be sought.

Side effects

Adverse effects reported with the use of Curiosin are rare and usually mild. They may occur at the beginning of treatment:

• Erythema (local redness);
• Mild burning or stinging sensation;
• Transient local pain.

The appearance of persistent signs of inflammation, infection or lack of signs of healing after a few days requires discontinuation of use and consultation with a specialist.

Interactions with other medicines and food

Curiosin is a topical preparation with no significant systemic absorption. Therefore, interactions with systemically administered drugs are practically non-existent.

However, concomitant application of other ointments or creams to the same area is not recommended, as potential physical-chemical interaction may alter the product's effectiveness.

Overdose

Given its topical use and non-toxic composition, the risk of overdose with Curiosin is practically zero. Repeated or excessive application is not associated with systemic adverse effects.

However, inappropriate use on infected or improperly cleaned wounds may delay the healing process.

Storage conditions

The product should be stored at temperatures between 5°C and 30°C, away from frost and direct sunlight. Check the packaging for integrity before first use. After opening, the tube should be discarded after 4 weeks, even if not completely used.

Specialised literature used

• PubMed, Treatment of partial thickness burns with Zn-hyaluronan: lessons from a pilot clinical study
• ScienceDirect, In vitro evaluation of the mucoadhesive properties of zinc hyaluronate
• PubMed, Management of paediatric facial burns with zinc-hyaluronan gel
• Springer Open, Hyaluronic acid: comprehensive review of a multifunctional biopolymer

FREQUENTLY ASKED QUESTIONS

There are no specific studies, but due to minimal local absorption and its harmless composition, Curiosin is considered safe. However, prior medical consultation is recommended.

No. Curiosin is a regenerating gel, not an antibiotic. It does not replace the treatment of bacterial infections prescribed by your doctor, but can only play an adjuvant role.

Curiosin can be useful in mild to moderate forms of acne, as it reduces inflammation, promotes regeneration and prevents scarring. However, it is advisable to seek the advice of a dermatologist and include Curiosin gel in a more complex treatment plan, according to medical instructions.